![](/img/cover-not-exists.png)
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial
Shiroiwa, Takeru, Fukuda, Takashi, Shimozuma, Kojiro, Mouri, Mitsuko, Hagiwara, Yasuhiro, Kawahara, Takuya, Ohsumi, Shozo, Hozumi, Yasuo, Sagara, Yoshiaki, Ohashi, Yasuo, Mukai, HirofumiVolume:
17
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-017-3774-7
Date:
December, 2017
File:
PDF, 857 KB
english, 2017